Profile data is unavailable for this security.
About the company
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
- Revenue in USD (TTM)26.85m
- Net income in USD-2.72m
- Incorporated1970
- Employees323.00
- LocationBGM Group LtdNo. 152 Hongliang East 1St StreetNo. 1703, Tianfu New DistrictCHENGDU 610200ChinaCHN
- Phone+86 2 864775180
- Websitehttps://www.bgmgroupltd.com/
More ▼
Mergers & acquisitions
| Acquired company | BGM:NAQ since announced | Transaction value |
|---|---|---|
| YX Management Co Ltd | -89.26% | 486.43m |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biostem Technologies Inc | 235.17m | 20.20m | 97.34m | 67.00 | 6.43 | 1.94 | 4.76 | 0.4139 | 0.9019 | 0.9019 | 11.60 | 2.98 | 2.82 | 2.61 | 4.65 | -- | 24.25 | -- | 55.07 | -- | 97.33 | -- | 8.59 | -- | 4.09 | -- | 0.0566 | -- | 1,708.93 | -- | 475.86 | -- | -- | -- |
| Alpha Cognition Inc | 7.43m | -19.47m | 106.10m | 52.00 | -- | 2.34 | -- | 14.29 | -1.37 | -1.37 | 0.5002 | 2.09 | 0.2894 | -- | 5.22 | 142,830.80 | -75.87 | -119.10 | -93.86 | -159.05 | 73.09 | -- | -262.18 | -- | 6.03 | -7.91 | 0.00 | -- | -- | -- | -6.34 | -- | -- | -- |
| Fortress Biotech Inc | 62.30m | -5.34m | 112.05m | 101.00 | -- | 2.00 | -- | 1.80 | -0.293 | -0.293 | 2.16 | 1.80 | 0.4039 | 1.50 | 4.35 | 616,861.40 | -34.90 | -54.95 | -51.59 | -102.13 | 71.56 | 62.39 | -86.41 | -227.71 | 1.97 | -10.63 | 0.4503 | -- | -31.76 | 9.50 | 18.61 | -- | 25.88 | -- |
| Whitehawk Therapeutics Inc | 14.38m | -15.62m | 134.32m | 22.00 | 20.98 | 0.8546 | -- | 9.34 | 0.1358 | 0.1358 | 0.2802 | 3.33 | 0.1138 | 0.5669 | 4.40 | 359,600.00 | -12.36 | -52.97 | -13.76 | -60.63 | 89.22 | -- | -108.58 | -372.67 | 16.76 | -- | 0.00 | -- | 6.69 | -- | 3.15 | -- | 47.49 | -- |
| NDT Pharmaceuticals Inc | -100.00bn | -100.00bn | 152.00m | 1.00 | -- | 0.8486 | -- | -- | -- | -- | -- | 1.12 | -- | -- | -- | -- | -- | -164.47 | -- | -452.47 | -- | -- | -- | -6,891.36 | -- | -- | 0.00 | -- | -100.00 | -- | 87.56 | -- | -- | -- |
| Karyopharm Therapeutics Inc | 142.53m | -124.62m | 157.11m | 279.00 | -- | -- | -- | 1.10 | -14.58 | -14.58 | 16.69 | -30.94 | 0.9977 | 1.34 | 4.48 | 510,860.20 | -87.24 | -48.75 | -181.85 | -63.64 | 95.93 | 97.09 | -87.43 | -92.03 | 0.9842 | -2.55 | -- | -- | -0.5451 | 28.85 | 46.60 | -- | -7.17 | -- |
| Sanara Medtech Inc | 101.90m | -6.24m | 168.97m | 141.00 | -- | 27.47 | -- | 1.66 | -0.7292 | -4.34 | 11.86 | 0.6885 | 1.28 | 2.47 | 8.78 | 722,724.30 | -8.03 | -15.12 | -10.00 | -18.64 | 92.25 | 88.92 | -6.29 | -14.70 | 1.60 | 0.3039 | 0.8801 | -- | 33.36 | 49.09 | -124.59 | -- | -33.05 | -- |
| BGM Group Ltd | 26.85m | -2.72m | 178.70m | 323.00 | -- | 0.5937 | -- | 6.66 | -0.2816 | -0.2816 | 1.38 | 1.85 | 0.2087 | 3.21 | 8.60 | 83,116.91 | -2.08 | -0.0792 | -2.36 | -0.1065 | 19.41 | 10.38 | -9.95 | -0.0921 | 1.45 | -0.3408 | 0.0087 | 2,560.18 | -45.99 | -11.45 | 81.46 | -- | 16.40 | -- |
| Tonix Pharmaceuticals Holding Corp | 10.30m | -99.22m | 193.70m | 81.00 | -- | 0.666 | -- | 18.81 | -20.11 | -20.11 | 1.69 | 22.73 | 0.0593 | 0.9665 | 2.75 | 127,148.10 | -57.12 | -61.84 | -63.76 | -68.67 | 34.31 | -- | -963.38 | -2,797.35 | 9.62 | -- | 0.00 | -- | 29.94 | -- | -11.47 | -- | 47.82 | -- |
| Coherus Oncology Inc | 83.57m | -187.47m | 194.60m | 161.00 | -- | 2.13 | -- | 2.33 | -1.62 | 1.33 | 0.721 | 0.7551 | 0.1636 | 1.76 | 0.9453 | 366,526.30 | -36.70 | -21.44 | -106.02 | -31.54 | 47.79 | 71.26 | -224.34 | -42.66 | 1.23 | -15.12 | 0.3656 | -- | 3.78 | -5.60 | 111.98 | -20.51 | -- | -- |
| Journey Medical Corp | 59.40m | -8.66m | 210.69m | 41.00 | -- | 7.87 | -- | 3.55 | -0.3645 | -0.3645 | 2.58 | 0.982 | 0.796 | 1.79 | 4.15 | 1,448,756.00 | -11.61 | -22.37 | -22.74 | -50.55 | 64.40 | 59.45 | -14.58 | -27.43 | 1.12 | -3.30 | 0.4928 | -- | -29.11 | 9.96 | -280.79 | -- | 44.27 | -- |
| Mediwound Ltd | 20.93m | -20.60m | 221.66m | 111.00 | -- | 4.41 | -- | 10.59 | -1.90 | -1.90 | 1.93 | 3.91 | 0.2475 | 4.59 | 3.69 | 188,576.60 | -24.36 | -35.38 | -35.12 | -48.39 | 18.53 | 32.18 | -98.43 | -71.55 | 2.48 | -- | 0.1416 | -- | 8.22 | -8.65 | -350.03 | -- | 51.27 | -- |
| Opus Genetics Inc | 14.63m | -68.20m | 251.03m | 18.00 | -- | 39.37 | -- | 17.16 | -1.76 | -1.76 | 0.2952 | 0.0925 | 0.3825 | -- | 3.85 | 812,944.40 | -178.28 | -76.30 | -330.00 | -86.90 | -- | -- | -466.09 | -185.79 | -- | -- | 0.1518 | -- | -42.30 | -- | -476.13 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to BGM Group Ltd's reporting currency: US Dollar USD
0.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Invesco Capital Management LLCas of 30 Sep 2025 | 162.89k | 0.10% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 49.14k | 0.03% |
| Geode Capital Management LLCas of 31 Dec 2025 | 47.16k | 0.03% |
| UBS Switzerland AG (Investment Management)as of 31 Dec 2025 | 2.43k | 0.00% |
| JPMorgan Securities LLC (Investment Management)as of 31 Dec 2025 | 1.75k | 0.00% |
| UBS Securities LLCas of 31 Dec 2025 | 461.00 | 0.00% |
| Virtu Americas LLCas of 30 Sep 2025 | 0.00 | 0.00% |
| Mariner LLCas of 31 Dec 2025 | 0.00 | 0.00% |
| Millennium Management LLCas of 30 Sep 2025 | 0.00 | 0.00% |
| RBC Capital Markets LLC (Investment Management)as of 30 Sep 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
